DocGo (DCGO) to Release Quarterly Earnings on Thursday

DocGo (NASDAQ:DCGO) is expected to post its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect DocGo to post earnings of ($0.09) per share for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, February 27, 2026 at 4:00 PM ET.

DocGo Stock Performance

Shares of DCGO opened at $0.81 on Thursday. DocGo has a 52-week low of $0.66 and a 52-week high of $5.53. The stock’s 50-day simple moving average is $0.84 and its 200 day simple moving average is $1.14. The stock has a market capitalization of $79.49 million, a price-to-earnings ratio of -1.56 and a beta of 0.95.

Hedge Funds Weigh In On DocGo

A number of institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC lifted its stake in DocGo by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock worth $1,984,000 after purchasing an additional 73,900 shares during the last quarter. State Street Corp increased its holdings in shares of DocGo by 2.0% in the fourth quarter. State Street Corp now owns 1,969,603 shares of the company’s stock worth $1,729,000 after buying an additional 39,125 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of DocGo by 205.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock valued at $707,000 after acquiring an additional 541,670 shares during the last quarter. Millennium Management LLC boosted its holdings in DocGo by 878.6% during the 3rd quarter. Millennium Management LLC now owns 766,210 shares of the company’s stock valued at $1,042,000 after acquiring an additional 687,911 shares during the period. Finally, Renaissance Technologies LLC grew its position in DocGo by 81.2% during the 4th quarter. Renaissance Technologies LLC now owns 565,535 shares of the company’s stock worth $496,000 after acquiring an additional 253,400 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on DCGO shares. Zacks Research upgraded shares of DocGo from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Canaccord Genuity Group lowered their target price on shares of DocGo from $1.60 to $1.50 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $3.21.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.